Comparative Effectiveness Research, Courage, and Technological Abandonment
31 Pages Posted: 30 Aug 2011 Last revised: 23 Oct 2011
Date Written: August 2011
Abstract
When a major study finds that a widely used medical treatment is no better than a less expensive alternative, do physicians stop using it? Policymakers hope that comparative effectiveness research will identify less expensive substitutes for widely-used treatments, but physicians may be reluctant to abandon profitable therapies. We examine the impact of the COURAGE trial, which found that medical therapy is as effective as percutaneous coronary intervention (PCI) for patients with stable angina, on practice patterns. Using hospital discharge data from US community, Veterans Administration, and English hospitals, we detect a moderate decline in PCI volume post-COURAGE. However, many patients with stable angina continue to receive PCI. We do not find differences in PCI volume trends by reimbursement scheme or hospitals' teaching status, ownership, or degree of vertical integration.
Suggested Citation: Suggested Citation
Do you have a job opening that you would like to promote on SSRN?
Recommended Papers
-
Managed Care, Technology Adoption, and Health Care: The Adoption of Neonatal Intensive Care
-
Managed Care and Technology Adoption in Health Care: Evidence from Magnetic Resonance Imaging
-
Technology Diffusion and Market Structure: Evidence from Infertility Treatment Markets
By Barton H. Hamilton and Brian Mcmanus
-
Quality and Investment Decisions in Hospital Care When Physicians are Devoted Workers
By Michele Moretto, Rosella Levaggi, ...
-
Managed Care and Medical Technology Growth
By Laurence C. Baker and Joanne Spetz
-
Mixed Signals: Public Policy and the Future of Health Care R&D
-
Managed Care and the Adoption of Hospital Technology: The Case of Cardiac Catheterization
-
By Rosella Levaggi, Michele Moretto, ...
-
By Rosella Levaggi, Michele Moretto, ...
